The SARS-CoV-2 has significantly burdened the healthcare systems worldwide thereby encouraging expanded remote monitoring as a way to reduce medical facility’s caseloads and minimise patients’ exposure to the virus. The trend will continue to accelerate even in a post-COVID scenario. Digital health experts believe the adoption of digital health solutions are likely to increase in the upcoming years and the regulations are also expected to be favourable for this industry.
From a technological point of view, AI and telemedicine have come forward to offer enhanced pandemic management capabilities. AI is increasingly being used to mine existing databases of medical information. For an instance, in February 2020, Benevolent AI, a UK-based company, proposed the use of existing drugs (drug repurposing) for COVID-19 treatment. In March, Kaggle, the world’s largest machine learning and data science community, launched a competition to analyze more than 47,000 scholarly articles about COVID-19 and related coronaviruses to learn about its origin, evolution, therapeutic, and social implications.
Telemedicine platforms also made their services available for free, including Kry in Sweden, Doctolib in France, and Adent Health in Denmark.